(Q27851763)

English

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study

scientific article

Statements

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study (English)
Valentina Guarneri
0 references
Antonio Frassoldati
0 references
Alberto Bottini
0 references
Katia Cagossi
0 references
Giancarlo Bisagni
0 references
Samanta Sarti
0 references
Alberto Ravaioli
0 references
Luigi Cavanna
0 references
Giovanni Giardina
0 references
Antonino Musolino
0 references
Laura Orlando
0 references
Fabrizio Artioli
0 references
Corrado Boni
0 references
Daniele Giulio Generali
0 references
Patrizia Serra
0 references
Michela Bagnalasta
0 references
Luca Marini
0 references
Federico Piacentini
0 references
Pierfranco Conte
0 references
1 June 2012
0 references
30
0 references
16
0 references
1989-95
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit